Status:
UNKNOWN
Catatonia: Effectiveness of Transcranial Direct Current Electrostimulation (CATATOES)
Lead Sponsor:
Centre Hospitalier St Anne
Conditions:
Catatonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nearly 10% of people hospitalized in psychiatry have a catatonic syndrome. The treatment of this syndrome is based on lorazepam and electro-convulsive therapy (ECT) in drug-resistant forms. ECT is the...
Detailed Description
Catatonia is a pathology combining affective, motor, behavioural and neuro-vegetative symptoms. Nearly 10% of people hospitalized in psychiatry have a catatonic syndrome. However, it is a severe disor...
Eligibility Criteria
Inclusion
- Men or women over 18 years old
- Under the care of the GHU PARIS Psychiatry and Neurosciences or EPS Ville Evrard.
- Suffering from an episode of catatonia according to the DSM-5 CRITERIA
- Persistence of catatonia criteria according to DSM-5 after 24 hours of lorazepam treatment or contraindication to lorazepam or poor tolerance to lorazepam
- Patient (or guardian) having given informed and written consent
- Beneficiary of a social security plan
Exclusion
- Malignant catatonia
- Pregnant or breastfeeding women
- Patients with contraindications to tCDS, namely patients with a defibrillator or a pacemaker, brain stimulator, presence of intracranial metals, uncovered craniectomy or after trepanning.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06139432
Start Date
December 1 2023
End Date
December 31 2025
Last Update
November 24 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CRC Pôle 93G03 Etablissement Public de Santé EPS Ville Evrard
Neuilly-sur-Marne, Île-de-France Region, France, 93330
2
Groupe Hospitalier Universitaire (GHU) Psychiatrie et Neurosciences
Paris, Île-de-France Region, France, 75014